Cochrane · systematic review · CD013160

Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma

Hwang, EC, Sathianathen, NJ, Jung, JH, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

UrologyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
3
No studies
3
Included studies
NR
No studies 3 · 50%Ungraded 0 · 0%Very low 2 · 33.3%Low 1 · 16.7%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Single‐dose intravesical chemotherapy instillation versus placebo or observation after nephroureterectomy for upper tract urothelial carcinoma

6 questions
OutcomeEffectEvidenceStatus / GRADE
Time to bladder cancer recurrence (absolute effect size estimates based on recurrence rate at 12 months)
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy
HR 0.51 [0.32, 0.82]2 studies · 311 participantsLow
Downgraded: risk of bias
Time to death from UTUC5
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy
no estimate extractedNRNo studies
Serious adverse events
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy
no estimate extracted2 studies · 311 participantsVery low
Downgraded: risk of bias
Time to death from any cause5
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy
no estimate extractedNRNo studies
Minor adverse events
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy
no estimate extracted1 study · 72 participantsVery low
Downgraded: risk of bias
Disease‐specific quality of life5
Single‐dose intravesical chemotherapy instillation vs placebo or observation after nephroureterectomy
no estimate extractedNRNo studies